Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Blueprint: Inventing the Future. Catalyzing STEAM Access. Closing the Gap.

Mandela Day 2024 Special: The New Student Pharmacist's Podcast in Xhosa and English | Usuku lukaMandela 2024 Isiqendu: I-Podcast yomfundi omtsha wePharmacist kwiXhosa nesiNgesi

18 Jul 2024

Description

“Education is the most powerful weapon which you can use to change the world.” - Nelson Mandela -- Ukubhiyozela uSuku lukaMandela, kwesi siqendu, sijonge ukubonisa udliwano-ndlebe lukaGqirha Robert Langer, Sc.D. kunye noGqr. Emery Brown, MD, PhD kwisiXhosa nakwisiNgesi. Yonwabela iinguqulelo ezimbini zodliwano-ndlebe. Sikwasebenzisa umculo woMhobe waseMzantsi Afrika ngasemva. -- Nceda uqaphele ukuba iimbono zale podcast zimele ezo zendwendwe zam (s) kunye nam. Sikhupha nayiphi na ilahleko nangayiphi na indlela. Nceda ujonge ingcali yezonyango eqinisekisiweyo yebhodi kunye norhulumente obhalisiweyo ukufumana iingcebiso kunye nokubonisana. Ezi azenzelwanga ukuba zithathe indawo yengcebiso ephilileyo yezonyango, iingcebiso okanye iingcebiso. Kwakhona, sikhupha nayiphi na ilahleko nangayiphi na indlela. --- To celebrate Mandela Day, in this episode, we aim to present the interviews of Dr. Robert Langer, Sc.D. and Dr. Emery Brown, MD, PhD in Xhosa and in English. Enjoy the dual translations of both interviews. -- Please note that the views of this podcast represent those of my guest (s) and I. We disclaim any loss in any way. Please see a medical professional who is board certified and state registered for advice and consultation. These are not designed to serve as a substitute for sound medical advice, suggestions or consultations. Again, we disclaim any loss in any way. ---

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.